CN104083519B - 一种调理中焦亏虚型虚劳症的中药茶饮 - Google Patents
一种调理中焦亏虚型虚劳症的中药茶饮 Download PDFInfo
- Publication number
- CN104083519B CN104083519B CN201410372100.7A CN201410372100A CN104083519B CN 104083519 B CN104083519 B CN 104083519B CN 201410372100 A CN201410372100 A CN 201410372100A CN 104083519 B CN104083519 B CN 104083519B
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- chinese medicine
- function
- preparata
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 201000010099 disease Diseases 0.000 title claims abstract description 35
- 239000003814 drug Substances 0.000 title claims abstract description 27
- 230000001105 regulatory Effects 0.000 title claims abstract description 15
- GUBGYTABKSRVRQ-YOLKTULGSA-N Maltose Natural products O([C@@H]1[C@H](O)[C@@H](O)[C@H](O)O[C@H]1CO)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 GUBGYTABKSRVRQ-YOLKTULGSA-N 0.000 claims abstract description 14
- 240000001008 Dimocarpus longan Species 0.000 claims abstract description 12
- 235000000235 Euphoria longan Nutrition 0.000 claims abstract description 12
- 239000009636 Huang Qi Substances 0.000 claims abstract description 10
- 239000002994 raw material Substances 0.000 claims abstract description 8
- 230000000694 effects Effects 0.000 abstract description 25
- 206010059866 Drug resistance Diseases 0.000 abstract description 3
- 239000000203 mixture Substances 0.000 abstract description 3
- 231100000957 no side effect Toxicity 0.000 abstract description 3
- 230000000857 drug effect Effects 0.000 abstract description 2
- 210000004369 Blood Anatomy 0.000 description 17
- 239000008280 blood Substances 0.000 description 17
- 210000000952 Spleen Anatomy 0.000 description 12
- 208000002193 Pain Diseases 0.000 description 9
- 230000036407 pain Effects 0.000 description 9
- 235000009508 confectionery Nutrition 0.000 description 8
- 210000004185 Liver Anatomy 0.000 description 5
- 210000004072 Lung Anatomy 0.000 description 5
- 231100000614 Poison Toxicity 0.000 description 5
- 210000002784 Stomach Anatomy 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 210000001015 Abdomen Anatomy 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 4
- 241000668709 Dipterocarpus costatus Species 0.000 description 4
- 208000008454 Hyperhidrosis Diseases 0.000 description 4
- 206010062717 Increased upper airway secretion Diseases 0.000 description 4
- 230000001629 suppression Effects 0.000 description 4
- 210000003734 Kidney Anatomy 0.000 description 3
- 206010027514 Metrorrhagia Diseases 0.000 description 3
- 206010033557 Palpitations Diseases 0.000 description 3
- 241001122767 Theaceae Species 0.000 description 3
- 230000036592 analgesia Effects 0.000 description 3
- 230000000844 anti-bacterial Effects 0.000 description 3
- 230000003110 anti-inflammatory Effects 0.000 description 3
- 230000033228 biological regulation Effects 0.000 description 3
- 230000003203 everyday Effects 0.000 description 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 3
- 235000013372 meat Nutrition 0.000 description 3
- 201000008125 pain agnosia Diseases 0.000 description 3
- 230000035900 sweating Effects 0.000 description 3
- 239000003440 toxic substance Substances 0.000 description 3
- WSVLPVUVIUVCRA-LEHKWIQMSA-N (2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-[(2R,3S,4R,5R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxane-3,4,5-triol;hydrate Chemical group O.O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O WSVLPVUVIUVCRA-LEHKWIQMSA-N 0.000 description 2
- 206010001580 Albuminuria Diseases 0.000 description 2
- 208000007502 Anemia Diseases 0.000 description 2
- 206010003119 Arrhythmia Diseases 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- 210000004204 Blood Vessels Anatomy 0.000 description 2
- 210000001124 Body Fluids Anatomy 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 206010007521 Cardiac arrhythmias Diseases 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N D-Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 208000001848 Dysentery Diseases 0.000 description 2
- 210000003743 Erythrocytes Anatomy 0.000 description 2
- 210000003414 Extremities Anatomy 0.000 description 2
- 206010016256 Fatigue Diseases 0.000 description 2
- 210000002216 Heart Anatomy 0.000 description 2
- 102000001554 Hemoglobins Human genes 0.000 description 2
- 108010054147 Hemoglobins Proteins 0.000 description 2
- 206010022437 Insomnia Diseases 0.000 description 2
- 210000002540 Macrophages Anatomy 0.000 description 2
- 206010027327 Menstrual disease Diseases 0.000 description 2
- 210000004165 Myocardium Anatomy 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- YKRGDOXKVOZESV-WRJNSLSBSA-N Paeoniflorin Chemical compound C([C@]12[C@H]3O[C@]4(O)C[C@](O3)([C@]1(C[C@@H]42)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)C)OC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-WRJNSLSBSA-N 0.000 description 2
- 210000002966 Serum Anatomy 0.000 description 2
- 208000010110 Spontaneous Platelet Aggregation Diseases 0.000 description 2
- 230000003042 antagnostic Effects 0.000 description 2
- 230000003266 anti-allergic Effects 0.000 description 2
- 230000001754 anti-pyretic Effects 0.000 description 2
- 239000002221 antipyretic Substances 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 230000022534 cell killing Effects 0.000 description 2
- 230000001055 chewing Effects 0.000 description 2
- 239000000812 cholinergic antagonist Substances 0.000 description 2
- 230000009089 cytolysis Effects 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000018984 mastication Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000017074 necrotic cell death Effects 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 210000000056 organs Anatomy 0.000 description 2
- 230000001717 pathogenic Effects 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000001737 promoting Effects 0.000 description 2
- 230000002048 spasmolytic Effects 0.000 description 2
- 230000002269 spontaneous Effects 0.000 description 2
- 230000000152 swallowing Effects 0.000 description 2
- 201000010874 syndrome Diseases 0.000 description 2
- 230000001225 therapeutic Effects 0.000 description 2
- -1 triterpenoid compound Chemical class 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010003549 Asthenia Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 210000001185 Bone Marrow Anatomy 0.000 description 1
- 210000004958 Brain cells Anatomy 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 206010008909 Chronic hepatitis Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 210000004351 Coronary Vessels Anatomy 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N D-sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 208000000325 Deficiency Disease Diseases 0.000 description 1
- 206010012601 Diabetes mellitus Diseases 0.000 description 1
- 208000002173 Dizziness Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 1
- 206010018836 Haematochezia Diseases 0.000 description 1
- 206010018987 Haemorrhage Diseases 0.000 description 1
- 210000002989 Hepatic Veins Anatomy 0.000 description 1
- 206010019641 Hepatic cirrhosis Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 208000006454 Hepatitis Diseases 0.000 description 1
- 206010062060 Hyperlipidaemia Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 210000003205 Muscles Anatomy 0.000 description 1
- 208000003067 Myocardial Ischemia Diseases 0.000 description 1
- 206010034568 Peripheral coldness Diseases 0.000 description 1
- 102000013566 Plasminogen Human genes 0.000 description 1
- 108010051456 Plasminogen Proteins 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000008425 Protein Deficiency Diseases 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 206010037549 Purpura Diseases 0.000 description 1
- 241001672981 Purpura Species 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 210000003324 RBC Anatomy 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 206010062104 Renal mass Diseases 0.000 description 1
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 1
- 206010040943 Skin ulcer Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- 229940031000 Streptococcus pneumoniae Drugs 0.000 description 1
- CZMRCDWAGMRECN-GDQSFJPYSA-N Sucrose Natural products O([C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O1)[C@@]1(CO)[C@H](O)[C@@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-GDQSFJPYSA-N 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 208000003441 Transfusion Reaction Diseases 0.000 description 1
- 210000003932 Urinary Bladder Anatomy 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000003213 activating Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000001154 acute Effects 0.000 description 1
- 201000005794 allergic hypersensitivity disease Diseases 0.000 description 1
- 201000000736 amenorrhea Diseases 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000001396 anti-anti-diuretic Effects 0.000 description 1
- 230000000879 anti-atherosclerotic Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000002180 anti-stress Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 230000000259 anti-tumor Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 210000003995 blood forming stem cell Anatomy 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- IVOMOUWHDPKRLL-KQYNXXCUSA-N cAMP Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-KQYNXXCUSA-N 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 230000032677 cell aging Effects 0.000 description 1
- 210000004027 cells Anatomy 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 230000001684 chronic Effects 0.000 description 1
- 230000000295 complement Effects 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 230000003247 decreasing Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 201000008286 diarrhea Diseases 0.000 description 1
- 230000035487 diastolic blood pressure Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 230000001882 diuretic Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 239000002158 endotoxin Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing Effects 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 229930003944 flavones Natural products 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000002949 hemolytic Effects 0.000 description 1
- 230000002607 hemopoietic Effects 0.000 description 1
- 210000001357 hemopoietic progenitor cell Anatomy 0.000 description 1
- 230000002008 hemorrhagic Effects 0.000 description 1
- 231100000753 hepatic injury Toxicity 0.000 description 1
- 230000001077 hypotensive Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 201000004044 liver cirrhosis Diseases 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 101710031899 moon Proteins 0.000 description 1
- 230000002107 myocardial Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000000242 pagocytic Effects 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000025627 positive regulation of urine volume Effects 0.000 description 1
- 230000001681 protective Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001603 reducing Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000001502 supplementation Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 230000003867 tiredness Effects 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N β-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
Abstract
本发明提供一种调理中焦亏虚型虚劳症的中药茶饮,其特征在于是由以下重量配比的中药原料制成:黄芪15‑40份,熟地10‑35份,桂枝10‑20份,白芍10‑20份,炙甘草5‑15份,饴糖5‑15份,红枣10‑20份,桂圆肉10‑20份,黑顺片2‑5份。组成本发明的各中药原料配伍合理、药效协同,用于调理中焦亏虚型虚劳症具有标本兼治、无毒副作用、疗效短、见效快、可治愈、无抗药性,且成方简单、服用方便等优点。
Description
技术领域:
本发明涉及中医药技术领域,具体地说就是一种调理中焦亏虚型虚劳症的中药茶饮。
背景技术:
虚劳又称虚损,是由于禀赋薄弱、后天失养及外感内伤等多种原因引起的,以脏腑功能衰退,气血阴阳亏损,日久不复为主要病机,以五脏虚证为主要临床表现的多种慢性虚弱症候的总称。
中焦是中医中人体部位名。三焦的中部,指上腹部分。它的主要功用是助脾胃,主腐熟水谷,泌糟粕,蒸津液,化精微,是血液营养生化的来源。中医认为气虚不能生血,血虚无以生气 ;气虚者,阳亦虚,血虚者,阴亦不足 ;阳损日久,累及于阴 ;阴虚日久,累及于阳。以致病势日渐发展,而病情趋于复杂。
而本症生活节奏加快和人口老龄化的今天,是为常见病、多发病,严重的危害着人们的身体建康,甚至生命安全。用西药治疗这样证候的疾病效果不明显,不良反应多,副作用大,费用高,难以从根本上解决问题。
发明内容:
本发明就是为了克服现有技术中的不足,提供一种用于调理中焦亏虚型虚劳症的中药茶饮,其具有标本兼治、无毒副作用、疗效短、见效快、可治愈、无抗药性,且成方简单、服用方便等功效。
本发明提供以下技术方案:
一种调理中焦亏虚型虚劳症的中药茶饮,其特征在于是由以下重量配比的中药原料制成:黄芪15-40份,熟地10-35份,桂枝10-20份,白芍10-20份,炙甘草5-15份,饴糖5-15份,红枣10-20份,桂圆肉10-20份,黑顺片2-5份。
配方优选:
黄芪25份,熟地20份,桂枝15份,白芍15份,炙甘草10份,饴糖10份,红枣15份,桂圆肉15份,黑顺片2份。
制备与服用方法:
按重量配比取上述各中药原料粉碎成80目粗粉后平均分为4等份后,每份1袋装入泡茶袋。
每天冲泡饮用4次,沸水冲入茶杯后加盖20分钟后,即可饮用,然后反复加水饮用直至茶水无味后再咀嚼药渣吞下,一个疗程为15天。
组成本发明的各中药原料的详细说明如下:
黄芪:味甘,性微温。归肺、脾、肝、肾经。具有益气固表、敛汗固脱、托疮生肌、利水消肿等功效。常用于治疗气虚乏力,中气下陷,久泻脱肛,便血崩漏,表虚自汗,痈疽难溃,久溃不敛,血虚萎黄,内热消渴,慢性肾炎,蛋白尿,糖尿病等症。本品有增强机体免疫功能、保肝、利尿、抗衰老、抗应激、降压和较广泛的抗菌作用。能消除实验性肾炎蛋白尿,增强心肌收缩力,调节血糖含量。黄芪不仅能扩张冠状动脉,改善心肌供血,提高免疫功能,而且能够延缓细胞衰老的进程。
熟地:味甘,微温。归肝、肾经。具有补血养阴,填精益髓等功效。常用于血虚萎黄,眩晕,心悸失眠,月经不调,崩漏等症。熟地黄水煎剂,可促进贫血动物红细胞、血红蛋白的恢复,加快多能造血干细胞、骨髓红系造血祖细胞的增殖、分化作用。熟地黄能显著抑制肝脏出血性坏死灶及单纯性坏死。对高脂食物引起的高脂血症,脂肪肝及大鼠内毒素引起的肝静脉出血症,均有抑制血栓形成的作用。认为对纤溶酶原的激活作用,是抗血栓形成的作用机制。熟地黄醇提取物对受角叉菜胶抑制的巨噬细胞功能有明显的保护作用;对抗体形成细胞有抑制作用。熟地黄有显著的降压作用,收缩压和舒张压均显著下降以及抗氧化作用。
桂枝:味辛、甘,性温。归心、肺、膀胱经。具有发汗解肌,温经通脉,助阳化气,散寒止痛等功效。常用于风寒感冒,脘腹冷痛,血寒经闭,关节痹痛,痰饮,水肿,心悸,奔豚等症。本品还具有扩张血管、调节血液循环、解热、镇痛、镇静、抗惊厥、抗炎、抗过敏、抗菌等作用。
白芍:性凉,味苦酸,微寒,具有补血养血、平抑肝阳、柔肝止痛。敛阴止汗等功效,适用于阴虚发热、月经不调、胸腹胁肋疼痛、四肢挛急,泻痢腹痛、自汗盗汗、崩漏、带下等症。本品中所含芍药甙有抗菌、解热、抗炎、增加冠状动脉流量、改善心肌营养血流、扩张血管、对抗急性心肌缺血、抑制血小板聚集、镇静、镇痛、解痉、抗溃疡、调节血糖的作用;白芍煎剂能抑制痢疾杆菌、肺炎链球菌、大肠杆菌、伤寒杆菌、溶血性链球菌、绿脓杆菌等。此外,研究表明:白芍对巨噬细胞的吞噬功能有增强作用。
甘草:味甘,性平。归胃、肺、脾经。具有补脾益气,清热解毒,祛痰止咳,缓急止痛,调和诸药等功效。常用于脾胃虚弱,倦怠乏力,心悸气短,咳嗽痰多,脘腹、四肢挛急疼痛,痈肿疮毒,缓解药物毒性、烈性等症。本品有解毒、祛痰、止痛、解痉、抗癌、调节机体免疫功能、抗心律失常、降血脂、抗动脉粥样硬化、抑制血小板聚集、抗肿瘤等药理作用。还可解附子毒。
饴糖:味甘,性温。归脾、胃、肺经。具有缓中,补虚,生津,润燥,补脾益气,缓急止痛、润肺止咳等功效。常用于劳倦伤脾,里急腹痛,肺燥咳嗽,吐血,口渴,咽痛,便秘等症。本品中主要含麦芽糖,并含维生素B和铁等,可解附子毒。
红枣:味甘,性温。归脾、胃经。具有益气补血、健脾和胃、袪风的功效,对治疗过敏性紫癜、贫血、高血压、急慢性肝炎和肝硬化患者的血清转氨酶增高以及预防输血反应等均有理想的效果;大枣含有三萜类化合物及环磷酸腺苷,有较强的抑癌、抗过敏作用;枣中含有抗疲劳作用的物质,能增强人的耐力;枣还具有减轻毒性物质对肝脏损害的功效;枣中的黄酮类化合物,有镇静降血压的作用。
桂圆肉:桂圆肉:味甘,性温。归心、脾经。具有补益心脾,养血安神等功效。常用于气血不足,心悸怔忡,健忘失眠,血虚萎黄等症。龙眼含丰富的葡萄糖、蔗糖和蛋白质等,含铁量也比较高,可在提高热能、补充营养的同时促进血红蛋白再生,从而达到补血的效果。研究发现,龙眼肉除了对全身有补益作用外,对脑细胞特别有效,能增强记忆,消除疲劳。
黑顺片:味辛、甘,性大热;有毒。归心、肾、脾经。具有回阳救逆,补火助阳,逐风寒湿邪等功效。常用于亡阳虚脱,肢冷脉微,阳痿,宫冷,心腹冷痛,虚寒吐泻,阴寒水肿,阳虚外感,寒湿痹痛等症。本品还具有扩张外周血管、提高小鼠体液免疫功能及豚鼠血清补体含量、抗心律失常、镇痛、镇静、抗炎以及强心和升压等作用。
本发明的优点在于:
组成本发明的各中药原料配伍合理、药效协同,用于调理中焦亏虚型虚劳症具有标本兼治、无毒副作用、疗效短、见效快、可治愈、无抗药性,且成方简单、服用方便等优点。
具体实施方式:
实施例1:
一种调理中焦亏虚型虚劳症的中药茶饮,其特征在于是由以下重量配比的中药原料制成:黄芪25份,熟地20份,桂枝15份,白芍15份,炙甘草10份,饴糖10份,红枣15份,桂圆肉15份,黑顺片3份。
实施例2:
一种调理中焦亏虚型虚劳症的中药茶饮,其特征在于是由以下重量配比的中药原料制成:黄芪20份,熟地13份,桂枝13份,白芍13份,炙甘草8份,饴糖8份,红枣10份,桂圆肉13,黑顺片2份。
实施例3:
一种调理中焦亏虚型虚劳症的中药茶饮,其特征在于是由以下重量配比的中药原料制成:黄芪35份,熟地30份,桂枝18份,白芍18份,炙甘草13份,饴糖13份,红枣20份,桂圆肉20份,黑顺片4份。
实施例1-3均使用以下制备与服用方法:
按重量配比取上述各中药原料粉碎成80目粗粉后平均分为4等份后,每份1袋装入泡茶袋。
每天冲泡饮用4次,沸水冲入茶杯后加盖20分钟后,即可饮用,然后反复加水饮用直至茶水无味后再咀嚼药渣吞下,一个疗程为15天。
一般资料:
2009年2月-2013年2月间,使用本发明对160例中焦亏虚型虚劳症的患者进行调理,患者中年龄最小的38岁、最大的62 岁,病情2个月-3年。随机分为:治疗组100例,对照组60例。两组年龄等资料无显著性差异,具有可比性。
治疗方法:
对照组口服益血生胶囊,按照说明书服用,疗程 30 天。
治疗组口服本发明按照具体实施例 1 制得的中药茶包,每天冲泡饮用4次。一个疗程为15天。
疗效标准 :
痊愈 :临床症状全部消失,试验室检查正常。
好转 :临床症状减轻,病情得到控制,实验检查改善或正常。
无效 :临床症状无明显好转或加重。
在治疗2个月后治疗结果如下:
治疗组:痊愈36例,好转57例,无效7例,总有效率93%。
对照组:痊愈8例,好转23例,无效29例,总有效率51.7%。
由此可见,本发明制得的药物能够安全有效调理中焦亏虚型虚劳症。
Claims (2)
1.一种调理中焦亏虚型虚劳症的中药茶饮,其特征在于是由以下重量配比的中药原料制成:黄芪15-40份,熟地10-35份,桂枝10-20份,白芍10-20份,炙甘草5-15份,饴糖5-15份,红枣10-20份,桂圆肉10-20份,黑顺片2-5份。
2.根据权利要求1中所述的一种调理中焦亏虚型虚劳症的中药茶饮,其特征在于是由以下重量配比的中药原料制成:黄芪25份,熟地20份,桂枝15份,白芍15份,炙甘草10份,饴糖10份,红枣15份,桂圆肉15份,黑顺片2份。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410372100.7A CN104083519B (zh) | 2014-07-31 | 一种调理中焦亏虚型虚劳症的中药茶饮 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410372100.7A CN104083519B (zh) | 2014-07-31 | 一种调理中焦亏虚型虚劳症的中药茶饮 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104083519A CN104083519A (zh) | 2014-10-08 |
CN104083519B true CN104083519B (zh) | 2016-11-30 |
Family
ID=
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1219399A (zh) * | 1997-12-08 | 1999-06-16 | 李养利 | 治疗胃疼、胃及十二指溃疡的药物及其该药物的使用方法 |
CN1915368A (zh) * | 2006-08-25 | 2007-02-21 | 袁爱仙 | 一种治疗严重型自汗症的汤剂药物及制备方法 |
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1219399A (zh) * | 1997-12-08 | 1999-06-16 | 李养利 | 治疗胃疼、胃及十二指溃疡的药物及其该药物的使用方法 |
CN1915368A (zh) * | 2006-08-25 | 2007-02-21 | 袁爱仙 | 一种治疗严重型自汗症的汤剂药物及制备方法 |
Non-Patent Citations (1)
Title |
---|
黄芪建中汤为主治疗消化性溃疡56 例疗效观察;柴廉明;《深圳中西医结合杂志》;20010228;第11卷(第1期);第34页左栏第1段、第3段 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103316208B (zh) | 具有补气养血、抗衰老、延年益寿的中药制剂 | |
CN100435831C (zh) | 治疗高血压、高血脂、肥胖症及更年期综合症的制剂及其制备方法 | |
CN103877263A (zh) | 一种红参、玛咖、绿茶提取物(茶氨酸)等复合中药抗疲劳养生制剂 | |
CN104173493A (zh) | 一种具有改善睡眠作用的药物组合物及其制备方法与应用 | |
CN105456822A (zh) | 一种育阴扶阳养生黄酒 | |
CN106110282A (zh) | 一种调理脾虚的中药组合物 | |
CN105031517A (zh) | 一种降三高的铁皮石斛保健茶及其制备方法 | |
CN104825801A (zh) | 一种预防和治疗心脑血管疾病的中药制剂 | |
CN102772704A (zh) | 老年病药物 | |
CN103549561A (zh) | 一种改善贫血体虚的保健汤 | |
CN102940730A (zh) | 治疗高血压的中药 | |
CN102552685B (zh) | 一种治疗失眠的中药汤剂 | |
CN103751745B (zh) | 一种治疗荨麻疹的中药混合物 | |
CN102579610A (zh) | 一种治疗脑出血的中药组合物及其制备方法 | |
CN111135235A (zh) | 一种预防和缓解急性酒精中毒或醉酒的组合物 | |
CN104337920A (zh) | 一种改善睡眠质量的中药组合物 | |
CN104189472A (zh) | 一种治疗原发性低血压病的中药组合物 | |
CN101745042B (zh) | 一种具有解酒保肝作用的组合物及其制备方法 | |
CN104083519B (zh) | 一种调理中焦亏虚型虚劳症的中药茶饮 | |
CN103920102A (zh) | 一种治疗原发性低血压的中药药物 | |
CN102266481B (zh) | 一种治疗慢性脑供血不足的中药制剂 | |
CN105147944B (zh) | 一种中药组合物、其制剂及其制备方法和应用 | |
CN104474342A (zh) | 一种适宜三高人群饮用的茶膏及其制备方法 | |
CN105727216A (zh) | 一种回阳救逆的中药配方及其制备方法 | |
CN103830649B (zh) | 一种治疗慢性酒精中毒的药物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
CP03 | Change of name, title or address |
Address after: 233000 Xinghua Road 189, Bengbu High-tech Zone, Anhui Province Patentee after: Bengbu fire Crane Pharmaceutical Limited by Share Ltd Address before: 233000 No. 200 Changqing South Road, Bengbu High-tech Development Zone, Anhui Province Patentee before: Bengbu Huohe Pharmaceutical Co., Ltd. |